Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

NCT02779140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Botulism

Interventions

BIOLOGICAL: NTM-1632
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)